Quality of life in 188 patients with myasthenia gravis in China

References

• Conti-Fine BM, Milani M, Kaminski HJ. Myasssthenia gravis: past, present, and future. J Clin Invest 2006;116:2843–54.
   PubMed Web of Science ®Google Scholar
• Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve 2008;37:141–9.
   PubMed Web of Science ®Google Scholar
• Padua L, Evoli A, Aprile I, et al. Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurol Sci 2001;22:363–9.
   PubMed Web of Science ®Google Scholar
• Mullins LL, Carpentier MY, Paul RH, Sanders DB. Disease-specific measure of quality of life for myasthenia gravis. Muscle Nerve 2008;38:947–56.
   PubMed Web of Science ®Google Scholar
• Paul RH, Nash JM, Cohen RA, et al. Quality of life and well-being of patients with myasthenia gravis. Muscle Nerve 2001;24:512–6.
   PubMed Web of Science ®Google Scholar
• Leonardi M, Raggi A, Antozzi C, et al. The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study. J Neurol 2010;257:98–102.
   PubMed Web of Science ®Google Scholar
• Raggi A, Leonardi M, Antozzi C, et al. Concordsance between severity of disease, disability and health-related quality of life in myasthenia gravis. Neurol Sci 2010;31:41–45.
   PubMed Web of Science ®Google Scholar
• Rostedt A, Padua L, Stalberg EV. Validation of the Swedish version of the disease-specific Myasthenia Gravis Questionnaire. Neurol Sci 2006;27:91–6.
   PubMed Web of Science ®Google Scholar
• Rostedt A, Padua L, Stalberg EV. Correlation between regional myasthenic weakness and mental aspects of quality of life. Eur J Neurol 2006;13:191–3.
   PubMed Web of Science ®Google Scholar
• Twork S, Wiesmeth S, Klewer J, et al. Quality of life and life circumstances in German myasthenia gravis patients. Health Qual Life Outcomes 2010;8:129. doi: 10.1186/1477-7525-8-129
   PubMed Web of Science ®Google Scholar
• Winter Y, Schepelmann K, Spottke AE, et al. Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol 2010;257:1473–81.
   PubMed Web of Science ®Google Scholar
• Kulkantrakorn K, Sawanyawisuth K, Tiamkao S. Factors correlating quality of life in patients with myasthenia gravis. Neurol Sci 2010;31:571–3.
   PubMed Web of Science ®Google Scholar
• Chen YT, Chang Y, Chiu HC, Yeh JH. Psychosocial aspects in myasthenic patients treated by plasmapheresis. J Neurol 2011;258:1240–6.
   PubMed Web of Science ®Google Scholar
• Burns TM, Conaway MR, Cutter GR, Sanders DB. Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis. Muscle Nerve 2008;38:957–63.
   PubMed Web of Science ®Google Scholar
• Burns TM, Grouse CK, Conaway MR, Sanders DB. Construct and concurrent validation of the MG-QOL15 in the practice setting. Muscle Nerve 2010;41:219–26.
   PubMed Web of Science ®Google Scholar
• Burns TM, Grouse CK, Wolfe GI, et al. The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis. Muscle Nerve 2011;43:14–8.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li H, Guo J, et al. Different molecular expression in thymoma with ocular or generalized myasthenia gravis. J Neurol Sci 2012;313:27–31.
   PubMed Web of Science ®Google Scholar
• Jaretzki AR, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the myasthenia gravis foundation of America. Neurology 2000;55:16–23.
   PubMed Web of Science ®Google Scholar
• Barohn RJ, McIntire D, Herbelin L, et al. Reliability testing of the quantitative myasthenia gravis score. Ann N Y Acad Sci. 1998;841:769–72.
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
   PubMed Web of Science ®Google Scholar
• Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50–5.
   PubMed Web of Science ®Google Scholar
• Li L, Wang HM, Shen Y. Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health 2003;57:259–63.
   PubMed Web of Science ®Google Scholar
• Gajdos P, Tranchant C, Clair B, et al. Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial. Arch Neurol 2005;62:1689–93.
   PubMedGoogle Scholar
• Wang W, Lopez V, Ying CS, Thompson DR. The psychometric properties of the Chinese version of the SF-36 health survey in patients with myocardial infarction in mainland China. Qual Life Res. 2006;15:1525–31.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Yang L, Chen Z, et al. Health-related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: a cross-sectional survey in China. Eur J Haematol 2007;78:518–23.
   PubMed Web of Science ®Google Scholar
• Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001;357:2122–8.
   PubMed Web of Science ®Google Scholar
• Padua L, Evoli A, Aprile I, et al. Quality of life in patients with myasthenia gravis. Muscle Nerve 2002;25:466–7.
   PubMed Web of Science ®Google Scholar
• Scott KR, Kothari MJ. Self-reported pain affects quality of life in myasthenia gravis. J Clin Neuromuscul Dis 2006;7:110–4.
   PubMedGoogle Scholar
• Wager TD, Rilling JK, Smith EE, et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004;303:1162–7.
   PubMed Web of Science ®Google Scholar
• Basta IZ, Pekmezovic TD, Peric SZ, et al. Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia). Neurol Sci 2012;33:1375–81.
   PubMed Web of Science ®Google Scholar
• Raggi A, Leonardi M, Mantegazza R, et al. Social support and self-efficacy in patients with myasthenia gravis: a common pathway towards positive health outcomes. Neurol Sci 2010;31:231–5.
   PubMed Web of Science ®Google Scholar
• Cavalcante P, Le Panse R, Berrih-Aknin S, et al. The thymus in myasthenia gravis: site of ‘innate autoimmunity’? Muscle Nerve 2011;44:467–84.
   PubMed Web of Science ®Google Scholar
• Marx A, Wilisch A, Schultz A, et al. Pathogenesis of myasthenia gravis. Virchows Arch 1997;430:355–64.
   PubMed Web of Science ®Google Scholar
• Remes-Troche JM, Tellez-Zenteno JF, Estanol B, et al. Thymectomy in myasthenia gravis: response, complications, and associated conditions. Arch Med Res 2002;33:545–51.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Utsugisawa K, Suzuki S, et al. Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study. BMJ Open 2011;1:e313.
   Google Scholar